Propanc Biopharma Inc. (PPCB) was uplisted to the Nasdaq from the OTC Markets, Pink Tier, on August 15, 2025.
Last week, the company priced an underwritten public offering of 1 million shares of its common stock, par value $0.001 per share, at a price of $4.00 per share. The offering is expected to yield approximately $4 million in gross proceeds. The offering is expected to close today, subject to customary closing conditions.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.